Purdue Ventures invests in cancer therapeutics firm
Purdue Ventures has invested $250,000 in TRIO Pharmaceuticals Inc., an antibody-based cancer therapeutics company founded by a Purdue University biophysics and structural biology alumnus. ... Read More